Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors

Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors

Background Atopic dermatitis (AD) profoundly impacts patients’ lives, necessitating long-term systemic treatments.Methods This retrospective study involved 709 severe AD patients receiving dupilumab. Drug survival (DS) was analyzed using Kaplan-Meier curves, evaluating reasons for discontinuation. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesca Barei, Paolo Calzari, Luca Valtellini, Alessandra Chiei Gallo, Gabriele Perego, Simona Tavecchio, Martina Zussino, Angelo V. Marzano, Silvia Ferrucci
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Dermatological Treatment
Subjects:
Atopic dermatitis
dupilumab
drug-survival
associate predictors
psoriasiform dermatitis
psoriasis
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2024.2404718
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items